GlassScriptPhysician profile
John G Anema
NPI 1053411215
$23,890.23
in general payments reported to CMS, 2019-2025
59 companies · $14K in 2025
The $14K reported for 2025 was more than what 95% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,324 · 2020: $731 · 2021: $1,787 · 2022: $1,712 · 2023: $2,290 · 2024: $1,753 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,940 · Food and Beverage: $6,717 · Travel and Lodging: $1,444 · Education: $236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,939.75 |
| Food and Beverage | $6,716.66 |
| Travel and Lodging | $1,444.25 |
| Education | $235.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $9,791.99 | 2019-2025 | Erleada, Akeega, Balversa |
| Bayer Healthcare Pharmaceuticals INC. | $3,182.81 | 2019-2025 | |
| Astellas Pharma US INC | $1,829.17 | 2019-2025 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $993.65 | 2023-2025 | Orgovyx, Gemtesa |
| Procept Biorobotics Corporation | $899.87 | 2022-2025 | Aquabeam Robotic System, Aquabeam System |
| Dendreon Pharmaceuticals LLC | $634.67 | 2019-2025 | Provenge |
| Myriad Genetic Laboratories, INC. | $588.74 | 2021-2025 | Prolaris |
| Myovant Sciences INC. | $517.99 | 2021-2022 | |
| Pfizer INC. | $432.86 | 2019-2025 | |
| Neotract INC. | $331.87 | 2019 | |
| Urogen Pharma, INC. | $310.68 | 2020-2025 | Jelmyto |
| Abbvie INC. | $281.41 | 2019-2025 | Lupron Depot |
| Ferring Pharmaceuticals INC. | $277.69 | 2019-2025 | Adstiladrin |
| Verity Pharmaceuticals INC. | $252.96 | 2022-2025 | Trelstar |
| Amgen INC. | $233.31 | 2019-2023 | Xgeva, Prolia |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $226.36 | 2019-2025 | Posluma |
| Coloplast Corp | $213.07 | 2020-2024 | Speedicath |
| Astrazeneca Pharmaceuticals LP | $212.03 | 2020-2025 | Onglyza, Lynparza |
| Teleflex LLC | $210.39 | 2021-2023 | Urolift |
| Janssen Scientific Affairs, LLC | $207.72 | 2020-2025 | Erleada, Pipeline |
| Accord Healthcare, INC. | $206.09 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $160.35 | 2020-2024 | Keytruda, Lynparza |
| Boston Scientific Corporation | $159.14 | 2019-2025 | Rezum Generator, Spaceoar Vue System - 10ml |
| Laborie Medical Technologies Corp. | $146.51 | 2022-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Tolmar Pharmaceuticals, INC. | $135.00 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $127.14 | 2024-2025 | |
| Endo Pharmaceuticals INC. | $125.69 | 2019-2023 | Aveed, Xiaflex, Edex |
| Tolmar, INC. | $113.83 | 2023-2025 | Jatenzo, Eligard |
| Olympus America INC. | $100.58 | 2020-2025 | Itind System |
| Seagen INC. | $84.99 | 2025 | |
| Immunitybio, INC. | $80.29 | 2024-2025 | |
| Coherus Oncology, INC. | $75.00 | 2021 | |
| Progenics Pharmaceuticals, INC. | $72.73 | 2023-2025 | Pylarify |
| E.R. Squibb & Sons, L.L.C. | $57.02 | 2021-2023 | Opdivo |
| Foundation Medicine, INC. | $54.16 | 2020-2023 | Foundationone Liquid Cdx |
| Histosonics, INC. | $39.44 | 2025 | |
| Antares Pharma, INC. | $38.81 | 2024-2025 | Xyosted |
| Avation Medical, INC. | $37.02 | 2025 | Vivally System |
| Travere Therapeutics, INC. | $34.42 | 2021 | |
| Cook Medical LLC | $32.49 | 2022-2024 | Cook |
| Ambu INC. | $30.07 | 2024 | |
| Edap Technomed INC | $29.99 | 2025 | |
| Celltrion USA INC. | $24.15 | 2025 | Vegzelma |
| Angiodynamics, INC. | $23.89 | 2025 | Nanoknife |
| Telix Pharmaceuticals | $23.75 | 2024 | Illuccix |
| Axogen | $22.44 | 2025 | |
| Organon LLC | $22.35 | 2025 | |
| Alexion Pharmaceuticals, INC. | $22.21 | 2019 | |
| Koelis INC. | $21.71 | 2023 | |
| Axonics, INC. | $19.94 | 2024 | Bulkamid |
| Integra Lifesciences Corporation | $17.81 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Genzyme Corporation | $17.80 | 2022 | |
| Photocure INC | $17.74 | 2024 | Cysview |
| Allergan, INC. | $15.85 | 2019 | |
| Cycle Pharmaceuticals INC | $15.74 | 2025 | Venxxiva |
| Endo USA, INC. | $15.02 | 2025 | Xiaflex, Aveed |
| Avyxa Pharma, LLC | $14.71 | 2025 | |
| Sun Pharmaceutical Industries INC. | $13.68 | 2019 | |
| Srs Medical Systems, INC. | $11.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Anema listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.